Skip to content
drillr.ai
Sign up

VOR

Vor Biopharma Inc.

NASDAQ · Healthcare · Biotechnology · US

$25.05
+3.34%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue28.0K——3.5M9.0M
Gross Profit(28.0K)——(3.5M)(9.0M)
Operating Expenses
R&D Expense76.8M321.5M93.3M94.3M64.5M
SG&A Expense70.7M50.1M27.9M31.7M19.9M
General & Admin Expense70.7M50.1M27.9M31.7M—
Selling & Marketing Expense—————
Other Expenses(451.0K)——(3.5M)—
Total Operating Expenses147.1M371.6M121.2M122.5M84.5M
Cost and Expenses147.1M371.6M121.2M126.0M93.4M
Operating Income (EBIT)(147.1M)(371.6M)(121.2M)(126.0M)(93.4M)
Non-Operating
Interest Income12.8M5.9M4.3M8.2M1.3M
Interest Expense—————
Net Interest Income12.8M5.9M4.3M8.2M1.3M
Other Non-Op Income/Expense774.9M(324.3M)4.3M8.2M1.3M
Non-Operating Income (excl Interest)(789.8M)324.3M(4.3M)(8.2M)(1.3M)
EBT (Pre-Tax Income)627.8M(696.0M)(116.9M)(117.9M)(92.1M)
Income Tax Expense—————
Bottom Line
Net Income627.8M(696.0M)(116.9M)(117.9M)(92.1M)
Earnings from Cont. Ops627.8M(696.0M)(116.9M)(117.9M)(92.1M)
Earnings from Discont. Ops—————
Bottom Line Net Income627.8M(696.0M)(116.9M)(117.9M)(92.1M)
Per Share
Basic EPS($325.79)($70.50)($34.00)($35.00)($46.60)
Diluted EPS($588.82)($70.50)($34.00)($35.00)($46.60)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding54.3M9.9M3.4M3.4M2.0M
Diluted Shares Outstanding54.3M9.9M3.4M3.4M2.0M
Profitability Metrics
EBITDA642.8M(693.1M)(113.4M)(114.4M)(83.1M)
D&A53.0K2.9M3.5M3.5M9.0M
EBIT642.7M(696.0M)(116.9M)(117.9M)(92.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026